Take Advantage of OA Benefits

FinELib consortium’s agreement with ACS offers authors an opportunity to publish their articles open access during the agreement term 2021 – 2023 without article processing charges (APC).

Under FinELib consortium’s agreement with Elsevier, authors can publish their articles open access without article processing charge (APC) in Elsevier hybrid journals eligible for the agreement.

FinELib consortium’s agreement with Emerald offers authors an opportunity to publish their articles under the CC BY-license with a free open access voucher.

This means that there is no article processing charge for the author.

FinELib consortium’s agreement with IEEE offers the opportunity to publish articles open access without an article processing charge in IEEE:s hybrid and fully open access journals.

Researchers can publish their articles open access in RSC hybrid journals without additional payment, since the costs have been covered as a part of FinELib consortium’s agreement.

Researchers can publish their articles open access without additional payment in SAGE hybrid journals or get a 20% discount on APC’s when publishing in SAGE Full OA journals, since the costs are covered as part of the FinELib consortium’s agreement.

Researchers get a 15% discount of the APC fee of Science Advances -journal. Science Advances is an online-only open access journal.

FinELib consortium’s agreement with Springer Nature includes open access publishing in Springer’s hybrid titles without article processing charge (APC).

The agreement between FinELib and Taylor & Francis gives the researchers of the subscribing member organisations an opportunity to publish a limited amount of articles open access without additional payment in the Taylor & Francis Open Select standard rate journals and in the Open Access journal Annals of Medicine.

FinELib consortium’s agreement with Wiley enables the researchers to publish their articles open access in Wiley’s Full OA and hybrid journals without additional payment.

FinELib consortium’s agreement with Wolters Kluwer Health offers authors an opportunity to publish articles with a free open access. This means that there is no article processing charge for the author.